Clinical Trials

366 enrolled

Breast Neoplasms

NCT04714190 2023-12-21

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

351 enrolled

Stomach Neoplasms

NCT00657878 2023-11-13

MITO-8

215 enrolled

Ovarian Neoplasms

NCT02584478 2023-11-08

AL3818

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00411138 2023-10-11

PORTEC-3

670 enrolled

Endometrial Neoplasms

NCT04201561 2023-06-26

SELENIUM

68 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00326456 2023-03-27

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

820 enrolled

Ovarian Neoplasms

NCT00660842 2023-03-24

MITO-7

800 enrolled

Ovarian Neoplasms, Neurotoxicity Syndromes

NCT01802749 2023-03-24

MITO16MANGO2b

406 enrolled

Ovarian Neoplasms

NCT05753865 2023-03-03

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

454 enrolled

Advanced Breast Cancer

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

498 enrolled

Uterine Cervical Neoplasms

NCT02639650 2022-06-03

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

214 enrolled

Gestational Trophoblastic Disease

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

1,871 enrolled

Breast Neoplasms

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05145218 2021-12-08

A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer

405 enrolled

Recurrent Platinum-resistant Ovarian Cancer

NCT01019616 2021-11-29

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

400 enrolled

Primary Breast Cancer

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

813 enrolled 14 charts

Endometrial Clear Cell Adenocarcinoma

NCT00108745 2021-09-30

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

1,157 enrolled 15 charts

Brenner Tumor, Fallopian Tube Neoplasms

NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

637 enrolled 18 charts

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04426955 2021-09-16

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

396 enrolled

Esophageal Neoplasms

NCT02934464 2021-09-13

ARMANI

280 enrolled

Stomach Neoplasms

NCT04679064 2021-08-27

NItCHE-MITO33

427 enrolled

Ovarian Neoplasms

NCT02667743 2021-03-17

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

454 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02526953 2021-02-09

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

314 enrolled

Anus Diseases, Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Neoplasms, Squamous Cell

NCT03912415 2020-09-18

FERMATA

316 enrolled

Uterine Cervical Neoplasms

NCT04416035 2020-08-31

NSCLC

608 enrolled

Advanced Non-squamous Non-small-cell Lung Cancer

NCT04502641 2020-08-06

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

160 enrolled

Head & Neck

Hypopharyngeal Neoplasms

NCT04405505 2020-05-28

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)

332 enrolled

Triple Negative Breast Neoplasms

NCT04203485 2020-05-08

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

762 enrolled

PD-L1 Positive Non-small Cell Lung Cancer

NCT02879513 2020-03-23

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

290 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT03693248 2019-12-10

ROCOCO

298 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04000295 2019-10-08

Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer

280 enrolled

Ovarian Neoplasms

NCT04073537 2019-08-29

Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer

386 enrolled

Squamous Non-small Cell Lung Cancer

NCT03949634 2019-05-14

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

272 enrolled

Breast Neoplasms

NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

200 enrolled

Triple Negative Breast Neoplasms

NCT00807768 2019-03-20

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

601 enrolled 13 charts

Other

Fatigue, Obesity, Neurotoxicity Syndromes

NCT03792074 2019-01-03

To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

560 enrolled

Non-squamous Cell Non-small Cell Lung Cancer

NCT03308552 2019-01-02

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

164 enrolled

Esophageal Neoplasms

NCT03328234 2019-01-02

Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

2 enrolled

IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer

NCT03475615 2018-03-23

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

215 enrolled

Stomach Neoplasms

NCT02629718 2018-03-16

SYSGO-003

700 enrolled

Uterine Cervical Neoplasms

NCT03366883 2018-01-09

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

420 enrolled

Esophageal Neoplasms

NCT03262948 2017-11-13

Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer

388 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02036164 2017-04-06

ACT-LACC

500 enrolled

Uterine Cervical Neoplasms

NCT02595554 2017-02-03

SYSGO002

220 enrolled

Uterine Cervical Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

486 enrolled

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

NCT02879097 2016-08-25

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00486668 2016-06-06

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

529 enrolled